Nitazene Control Act of 2025
Sponsor

- Veterans$4,000k
Full profile: /officials/V000138
Source: Congress.gov · FEC
Cosponsors (30)
Members who have signed on to support this bill since introduction. Source: Congress.gov.
- Michael Baumgartner (R-WA-5)Original· 2025-09-16
- Andy Harris (R-MD-1)· 2025-10-24
- Brian K. Fitzpatrick (R-PA-1)· 2025-11-07
- Donald G. Davis (D-NC-1)· 2025-11-18
- Daniel S. Goldman (D-NY-10)· 2025-11-19
- Richard McCormick (R-GA-7)· 2025-11-19
- David J. Taylor (R-OH-2)· 2025-11-28
- Ryan Mackenzie (R-PA-7)· 2025-12-10
- Deborah K. Ross (D-NC-2)· 2025-12-16
- Glenn Thompson (R-PA-15)· 2025-12-16
- Mike Kelly (R-PA-16)· 2025-12-16
- Pat Harrigan (R-NC-10)· 2025-12-16
- Robert F. Onder, Jr. (R-MO-3)· 2025-12-18
- Robert P. Bresnahan, Jr. (R-PA-8)· 2025-12-18
- Chrissy Houlahan (D-PA-6)· 2025-12-19
- Michael Lawler (R-NY-17)· 2025-12-19
- Joe Neguse (D-CO-2)· 2026-01-07
- Mike Carey (R-OH-15)· 2026-01-07
- August Pfluger (R-TX-11)· 2026-01-12
- Brandon Gill (R-TX-26)· 2026-01-12
- Sam T. Liccardo (D-CA-16)· 2026-01-13
- Susie Lee (D-NV-3)· 2026-01-13
- Derek Schmidt (R-KS-2)· 2026-02-10
- Maria Elvira Salazar (R-FL-27)· 2026-02-13
- James R. Baird (R-IN-4)· 2026-02-20
- Thomas R. Suozzi (D-NY-3)· 2026-03-03
- Randy Fine (R-FL-6)· 2026-04-15
- Russell Fry (R-SC-7)· 2026-04-15
- Maggie Goodlander (D-NH-2)· 2026-04-22
- Matt Van Epps (R-TN-7)· 2026-05-11
Latest Action
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2025-09-16
Source: Congress.gov
Committee Activity
Currently in
- House Committee on the JudiciaryReferred To · 2025-09-16
- House Committee on Energy and CommerceReferred To · 2025-09-16
Previously
- Energy and Commerce CommitteeReferred To · 2025-09-16
- Judiciary CommitteeReferred To · 2025-09-16
Plain-English Summary
The bill would classify nitazene, a synthetic opioid, as a controlled substance under federal law, making it illegal to manufacture, distribute, or possess without authorization. This would give law enforcement tools to prosecute people involved in nitazene trafficking and production, similar to how they handle other dangerous drugs like fentanyl. The change aims to address the growing public health threat from nitazene, which has been increasingly found in illicit drug supplies and linked to overdose deaths.
AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.
Subjects
Related legislation
Bills by the same sponsor or covering overlapping subjects.
- HR10199Sell Your Stocks or Step Down ActReferred to Committee · 2026-08-31
- HR10198Federal Worker Protection ActReferred to Committee · 2026-08-31
- HR10081No Utility Junk Fees ActReferred to Committee · 2026-08-10
- HR10080Energy Utility Lobbying Ban ActReferred to Committee · 2026-08-10